|
Category Archives: AZBio News
Phoenix Based Paradigm Diagnostics has raised $19.8M in less than 2 Years
Paradigm Diagnostics Inc. raised $8.9 million in venture capital to market its genetic profiling test aimed at personalized medicine. The round was led by San Diego-based Mesa Verde Venture Partners, along with New York-based Science Ventures LLC. Both have invested in Paradigm in the past. The investment brings the total amount raised by the company to $19.8 million since the bioscience firm’s first $3.5 million raise in December 2016. Read the latest filing here.Continue reading
University of Arizona Cancer Center and Banner-University Medical Center Tucson Join the Precision Oncology Alliance Powered by Caris Life Sciences
Clinical Partners Join Alliance to Advance Precision Medicine in OncologyContinue reading
Helios Scholars at TGen learn teamwork, technique and tenacity
Symposium caps 8-week internship of real-life biomedical research sponsored by Helios Education FoundationContinue reading
First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials
The Critical Path Institute’s (C-Path) Critical Path for Parkinson’s Consortium (CPP), in partnership with Parkinson’s UK, announces that the European Medicines Agency (EMA) has issued a positive qualification opinion on an imaging test (biomarker) as a tool to enrich Parkinson’s clinical trials. The purpose of this enrichment biomarker is to serve as a measurement that can be used to select people with Parkinson’s who are most suitable to take part in clinical trials.Continue reading
UA Clinical Trial to Repurpose Ketamine for Parkinson’s Patients
The best-known treatment for Parkinson’s disease isn’t perfect. Named levodopa, the drug can treat the stiffness and slowness of movement associated with the debilitating disease.Continue reading
House Bill to Repeal the Medical Device Tax Passes with Strong Bi-Partisan Support.
H.R. 184 the Protect Medical Innovation Act which would repeal the Medical Device Excise Tax passed in the U.S House of Representatives on July 24, 2018. (283 Ayes; 132 Nayes; 13 Not Voting) Seven members of Arizona’s nine person House Delegation both co-sponsored and voted in support of of the bill. The next step is the Senate. Continue reading
TGen-led study shows mutated gene is likely cause of a 3-year old girl’s severe disorder
Damaged gene FBXO28 is linked to patient at TGen’s Center for Rare Childhood DisordersContinue reading
The Fostering Innovation Act and the HALOS Act pass in the U.S. House of Representatives
The House of Representatives on July 17, 2018 passed two bills designed to better equip job creators in our state to grow and thrive.Continue reading